Article in Biomolecules, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
2 citing papers in PubMed, 4 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
7 authors at 1 institution in 1 country.
Kelly AcunaDepartment of Ophthalmology, Miami VA Medical Center, Miami, FL 33136, USA.ORCID 0000-0001-8158-5263
Anjalee ChoudharyDepartment of Ophthalmology, Miami VA Medical Center, Miami, FL 33136, USA.
Elyana LocatelliDepartment of Ophthalmology, Miami VA Medical Center, Miami, FL 33136, USA.ORCID 0000-0001-7065-7196
Daniel A RodriguezDepartment of Ophthalmology, Miami VA Medical Center, Miami, FL 33136, USA.ORCID 0000-0001-7682-6106
Eden R MartinJohn T. MacDonald Foundation Department of Human Genetics, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
Roy C LevittDepartment of Ophthalmology, Bascom Palmer Eye Institute, University of Miami, Miami, FL 33136, USA.
Anat GalorDepartment of Ophthalmology, Miami VA Medical Center, Miami, FL 33136, USA.ORCID 0000-0002-3026-6155
University of Miami · US
Funding
Shared Equipment ModuleP30EY014801 · NEI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Abigail S Hackam · 2004 to 2026
$12.2M
Tear protein biomarkers of refractive surgery painR61EY032468 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI AICHER, SUE A, GALOR, ANAT · 2020 to 2022
$2.0M
Dry Eye and MicroenvironmentR01EY026174 · NEI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI GALOR, ANAT, KUMAR, NARESH · 2016 to 2020
$1.9M
Disease Modifying Analgesia with CA8 Gene TherapyUG3NS123964 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI LEVITT, ROY C. · 2021 to 2021
$1.5M
Disease Modifying Analgesia with CA8 Gene TherapyUH3NS123964 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI LEVITT, ROY C. · 2023 to 2023
$1.1M
Long Acting Local Analgesics: HSV-CA8 BiotherapeuticsR21NS105880 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI LEVITT, ROY C. · 2018 to 2018
$701k
A pilot study of the safety and feasibility of transcutaneous electrical nerve stimulation (TENS) for chronic ocular painI21RX003883 · VA · MIAMI VA HEALTH CARE SYSTEM · PI FELIX, ELIZABETH ROY · 2022 to 2023
–
Neural mechanisms underlying photophobia and dry eyeI01CX002015 · VA · MIAMI VA HEALTH CARE SYSTEM · PI Anat Galor · 2020 to 2026
–
Lipid mediators and their signaling in ocular surface inflammation and meibomian gland dysfunctionI01BX004893 · VA · MIAMI VA HEALTH CARE SYSTEM · PI GALOR, ANAT, MANDAL, NAWAJES · 2021 to 2025
–
BLRD VA I01 BX004893CSRD VA I01 CX002015Department of Defense Gulf War Illness Research Program (GWIRP) W81XWH-20-1-0579Department of Defense Vision Research Program (VRP) W81XWH-20-1-0820DoD W81XWH-19-1-0525NEI NIH HHS P30 EY014801NEI NIH HHS R01 EY026174NEI NIH HHS R61 EY032468NINDS NIH HHS 3R21NS105880-01S1NINDS NIH HHS R21 NS105880NINDS NIH HHS UG3 NS123964NINDS UG3 NS123964OculisResearch to Prevent Blindness Unrestricted Grant GR004596RRD VA I21 RX003883Wallace H. Coulter Foundation
6 · The paper itself
Abstract
The goal of the study was to examine whether a genetic polymorphism in tumor necrosis factor receptor 1 (
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Impact of Tumor Necrosis Factor Receptor 1 ( · full record | OpenQuestion